Our results show that following combination treatment with Avastin plus FO and Se, exerts dose-dependent inhibitory effects on the activation of HIF-1α/HIF-2α, HSP90 along with decreased expression of COX-2 in TNBC tumor tissues in a dose-dependent manner. The gene discussed is EPAS1; the disease is neoplasm.